4//SEC Filing
Sullivan Eric 4
Accession 0001209191-17-047864
CIK 0001293971other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:02 PM ET
Size
22.9 KB
Accession
0001209191-17-047864
Insider Transaction Report
Form 4
Sullivan Eric
Principal Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2017-08-04$50.51/sh+201$10,153→ 5,875 total - Exercise/Conversion
Common Stock
2017-08-04$56.30/sh+244$13,737→ 6,119 total - Sale
Common Stock
2017-08-04$95.21/sh−445$42,370→ 5,674 total - Exercise/Conversion
Stock Options (right to buy)
2017-08-03−250→ 750 totalExercise: $20.70Exp: 2023-12-02→ Common Stock (250 underlying) - Exercise/Conversion
Stock Option (right to buy)
2017-08-03−166→ 854 totalExercise: $24.47Exp: 2024-03-03→ Common Stock (166 underlying) - Exercise/Conversion
Stock Option (right to buy)
2017-08-04−201→ 5,868 totalExercise: $50.51Exp: 2026-03-01→ Common Stock (201 underlying) - Exercise/Conversion
Stock Option (right to buy)
2017-08-04−244→ 8,558 totalExercise: $56.30Exp: 2026-08-01→ Common Stock (244 underlying) - Exercise/Conversion
Common Stock
2017-08-03$20.70/sh+250$5,175→ 5,924 total - Exercise/Conversion
Common Stock
2017-08-03$24.47/sh+166$4,062→ 6,090 total - Sale
Common Stock
2017-08-03$92.35/sh−416$38,418→ 5,674 total
Holdings
- 300(indirect: By Spouse)
Common Stock
Footnotes (6)
- [F1]The range in prices for the transaction reported on this line was $95.10 to $95.30. The average weighted price was $95.2128. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]Equity grants held by the reporting person's spouse, who is employed by the issuer
- [F3]This option vests over a four-year period, at a rate of twenty-five percent (25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
- [F4]This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
- [F5]This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017, and in 36 equal monthly installments.
- [F6]This option vests over a four-year period, at a rate of twenty-five percent (25%) on July 4, 2017 and in 36 equal monthly installments thereafter.
Documents
Issuer
bluebird bio, Inc.
CIK 0001293971
Entity typeother
Related Parties
1- filerCIK 0001601797
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 4:02 PM ET
- Size
- 22.9 KB